Mitochondrial DNA Haplogroups and Breast Cancer Risk Factors in the Avon Longitudinal Study of Parents and Children (ALSPAC)

Show simple item record

dc.contributor Sistema FMUSP-HC: Faculdade de Medicina da Universidade de São Paulo (FMUSP) e Hospital das Clínicas da FMUSP
dc.contributor.author RILEY, Vivienne
ERZURUMLUOGLU, A. Mesut
RODRIGUEZ, Santiago
BONILLA, Carolina FMUSP-HC
dc.date.issued 2018
dc.identifier.citation GENES, v.9, n.8, article ID 395, 31p, 2018
dc.identifier.issn 2073-4425
dc.identifier.uri http://observatorio.fm.usp.br/handle/OPI/29603
dc.description.abstract The relationship between mitochondrial DNA (mtDNA) and breast cancer has been frequently examined, particularly in European populations. However, studies reporting associations between mtDNA haplogroups and breast cancer risk have had a few shortcomings including small sample sizes, failure to account for population stratification and performing inadequate statistical tests. In this study we investigated the association of mtDNA haplogroups of European origin with several breast cancer risk factors in mothers and children of the Avon Longitudinal Study of Parents and Children (ALSPAC), a birth cohort that enrolled over 14,000 pregnant women in the Southwest region of the UK. Risk factor data were obtained from questionnaires, clinic visits and blood measurements. Information on over 40 independent breast cancer risk factor-related variables was available for up to 7781 mothers and children with mtDNA haplogroup data in ALSPAC. Linear and logistic regression models adjusted for age, sex and population stratification principal components were evaluated. After correction for multiple testing we found no evidence of association of European mtDNA haplogroups with any of the breast cancer risk factors analysed. Mitochondrial DNA haplogroups are unlikely to underlie susceptibility to breast cancer that occurs via the risk factors examined in this study of a population of European ancestry.
dc.description.sponsorship · UK Medical Research
· Wellcome Trust [102215/2/13/2]
· University of Bristol
· Medical Research Council [MR/K002767/1]
· Cancer Research UK [C18281/A19169]
· MSc/PgDip/PgCert Genomic Medicine program at the University of Exeter
· University of Bristol [G0600705, MC_UU_12013/19),]
· Integrative Cancer Epidemiology Programme - Cancer Research UK program [C18281/A19169]
dc.language.iso eng
dc.publisher MDPI
dc.relation.ispartof Genes
dc.rights openAccess
dc.subject mitochondrial DNA; haplogroups; breast cancer; risk factors; ALSPAC; Europeans
dc.subject.other human mtdna haplogroups; association; testosterone; metaanalysis; childhood; mutations; receptor; insulin; height; repair
dc.title Mitochondrial DNA Haplogroups and Breast Cancer Risk Factors in the Avon Longitudinal Study of Parents and Children (ALSPAC)
dc.type article
dc.rights.holder Copyright MDPI
dc.description.group LIM/38
dc.identifier.doi 10.3390/genes9080395
dc.identifier.pmid 30071701
dc.type.category original article
dc.type.version publishedVersion
hcfmusp.author BONILLA, Carolina:FM:
hcfmusp.author.external · RILEY, Vivienne:Univ Exeter, MSc Genom Med Programme, G7,Coll House,St Lukes Campus, Exeter EX2 4TE, Devon, England
· ERZURUMLUOGLU, A. Mesut:Univ Leicester, Dept Hlth Sci, Genet Epidemiol Grp, Leicester LE1 7RH, Leics, England; Univ Bristol, Bristol Med Sch, Populat Hlth Sci, MRC Integrat Epidemiol Unit, Oakfield House, Bristol BS8 2BN, Avon, England
· RODRIGUEZ, Santiago:Univ Bristol, Bristol Med Sch, Populat Hlth Sci, MRC Integrat Epidemiol Unit, Oakfield House, Bristol BS8 2BN, Avon, England
hcfmusp.origem.id WOS:000443615400025
hcfmusp.origem.id 2-s2.0-85051300625
hcfmusp.publisher.city BASEL
hcfmusp.publisher.country SWITZERLAND
hcfmusp.relation.reference · Bandelt HJ, 2008, INT J ANDROL, V31, P450, DOI 10.1111/j.1365-2605.2007.00786.x
· Blein S, 2015, BREAST CANCER RES, V17, DOI 10.1186/s13058-015-0567-2
· Boyd A, 2013, INT J EPIDEMIOL, V42, P111, DOI 10.1093/ije/dys064
· Cancer Research UK, BREAST CANC
· Chinnery PF, 2007, J MED GENET, V44, DOI 10.1136/jmg.2007.048876
· Chinnery PF, 2010, LANCET NEUROL, V9, P498, DOI 10.1016/S1474-4422(10)70083-1
· Croteau DL, 1999, MUTAT RES-DNA REPAIR, V434, P137, DOI 10.1016/S0921-8777(99)00025-7
· de Bruijn KMJ, 2013, BRIT J SURG, V100, P1421, DOI 10.1002/bjs.9229
· Ebner S, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0135622
· Emery LS, 2015, AM J HUM GENET, V96, P183, DOI 10.1016/j.ajhg.2014.12.015
· Erzurumluoglu AM, 2018, GENES-BASEL, V9, DOI 10.3390/genes9010045
· Fachal L, 2015, AM J MED GENET B, V168, P54, DOI 10.1002/ajmg.b.32276
· Fachal L, 2014, J HUM GENET, V59, P411, DOI 10.1038/jhg.2014.46
· Fraenkel M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070980
· Fraser A, 2013, INT J EPIDEMIOL, V42, P97, DOI 10.1093/ije/dys066
· Grant SFA, 2012, INT J OBESITY, V36, P80, DOI 10.1038/ijo.2011.206
· Grzybowska-Szatkowska L, 2012, MOL MED REP, V6, P923, DOI 10.3892/mmr.2012.1027
· Gunnell D, 2004, J CLIN ENDOCR METAB, V89, P213, DOI 10.1210/jc.2003-030507
· Hendrickson SL, 2008, AIDS, V22, P2429, DOI 10.1097/QAD.0b013e32831940bb
· HOLM S, 1979, SCAND J STAT, V6, P65
· Howe LJ, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-10871-4
· Jeffreys M, 2011, CANCER CAUSE CONTROL, V22, P945, DOI 10.1007/s10552-011-9767-y
· Kenney MC, 2014, BBA-MOL BASIS DIS, V1842, P208, DOI 10.1016/j.bbadis.2013.10.016
· Kirkwood B.R., 2007, MED STAT
· Kloss-Brandstatter A, 2011, HUM MUTAT, V32, P25, DOI 10.1002/humu.21382
· Knoll N, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094882
· Maisonet M, 2015, ENVIRON HEALTH PERSP, V123, P1325, DOI 10.1289/ehp.1408847
· Mandavilli BS, 2002, MUTAT RES-FUND MOL M, V509, P127, DOI 10.1016/S0027-5107(02)00220-8
· Mishmar D, 2003, P NATL ACAD SCI USA, V100, P171, DOI 10.1073/pnas.0136972100
· Mosquera-Miguel A, 2008, CANCER RES, V68, P623, DOI 10.1158/0008-5472.CAN-07-2385
· Nardelli C, 2013, BIOMED RES INT, DOI 10.1155/2013/631082
· Ong K, 2000, J CLIN ENDOCR METAB, V85, P4266, DOI 10.1210/jc.85.11.4266
· Pardo-Seco J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073567
· Pereira L, 2005, INT J ANDROL, V28, P241, DOI 10.1111/j.1365-2605.2005.00539.x
· Rego I, 2010, ANN RHEUM DIS, V69, P210, DOI 10.1136/ard.2008.105254
· Richards M, 2002, AM J HUM GENET, V71, P1168, DOI 10.1086/342930
· Robinson MR, 2015, NAT GENET, V47, P1357, DOI 10.1038/ng.3401
· Rohan TE, 2010, J ONCOL, DOI 10.1155/2010/604304
· Rojas K, 2016, CLIN OBSTET GYNECOL, V59, P651, DOI 10.1097/GRF.0000000000000239
· Royrvik EC, 2016, MOL HUM REPROD, V22, P809, DOI 10.1093/molehr/gaw062
· Ruiz-Pesini E, 2000, AM J HUM GENET, V67, P682, DOI 10.1086/303040
· Salas A, 2015, J GENET GENOMICS, V42, P169, DOI 10.1016/j.jgg.2015.03.002
· Salas A, 2014, BMC CANCER, V14, DOI 10.1186/1471-2407-14-659
· Salas A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008347
· Schon EA, 2012, NAT REV GENET, V13, P878, DOI 10.1038/nrg3275
· Sequeira ME, 2017, BRIT J PSYCHIAT, V210, P39, DOI 10.1192/bjp.bp.115.168617
· Shaheen SO, 2007, ALLERGY, V62, P25, DOI 10.1111/j.1398-9995.2006.01240.x
· Terry MB, 2004, JAMA-J AM MED ASSOC, V291, P2433, DOI 10.1001/jama.291.20.2433
· Tommasi S, 2014, INT J ONCOL, V44, P1691, DOI 10.3892/ijo.2014.2324
· van Oven M, 2009, HUM MUTAT, V30, pE386, DOI 10.1002/humu.20921
· Wang F, 2013, ANN ONCOL, V24, P2724, DOI 10.1093/annonc/mdt283
· World Cancer Research Fund/American Institute for Cancer Research, 2017, DIET NUTR PHYS ACT B
· Yang TL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021595
dc.description.index PubMed
hcfmusp.citation.scopus 2
hcfmusp.citation.wos 2
hcfmusp.affiliation.country Brasil
hcfmusp.affiliation.country Inglaterra


Files in this item

This item appears in the following Collection(s)

Show simple item record

Search DSpace



Browse

My Account

Statistics